Trexquant Investment »

Lexeo Therapeutics shares owned by Trexquant Investment

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Trexquant Investment from 13F filings

Historical chart of Trexquant Investment investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Trexquant Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Trexquant Investment

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.5M 315k 4.66

More positions owned by Trexquant Investment

NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Micron Technology Put Option (MU)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
JPMorgan Chase & Co. Call Option (JPM)
Alphabet Cap Stk Cl C Call Option (GOOG)
Meta Platforms Cl A Call Option (META)
Intuit Call Option (INTU)
Costco Wholesale Corporation Put Option (COST)
Palantir Technologies Cl A Put Option (PLTR)
Broadcom Call Option (AVGO)
Eli Lilly & Co. Call Option (LLY)

View all positions for Trexquant Investment

Top funds holding Lexeo Therapeutics

Suvretta Capital Management
Affinity Asset Advisors
BlackRock
RA Capital Management
Henderson Group
Frazier Life Sciences Management
Vestal Point Capital
Paradigm Biocapital Advisors
Jupiter Topco
OrbiMed Advisors
Citadel Advisors
State Street Corporation
Vanguard Capital Management
Millennium Management
Woodline Partners

View all funds holding Lexeo Therapeutics